For generations, suicide and its symptoms were the health crisis no one wanted to talk about. Some of the top psychiatry researchers in Canada will gather this Friday for the Jewish General Hospital’s (JGH) Sixth Annual Psychiatry Research Day to shed light on this important problem, and will present recent research on the prediction and prevention of suicide, and the treatment of its symptoms. 
Entitled ‘Suicide in Context: Perspectives on Risks, Assessment and Treatment’, the event is designed to update local health-care and social service professionals on the latest developments in suicide prevention research at the JGH.
“The work of clinician-scientists from the JGH Psychiatry Department is important in helping us to identify who is at risk for suicide, how to identify these people, and what we can do to help them,” said Dr. Phyllis Zelkowitz, the event organizer and director of the Psychiatry Research Division at the JGH.
Dr. Michael Bond, Chief of the JGH Department of Psychiatry will present opening remarks.
Dr. Robert Biskin, a McGill Department of Psychiatry resident specializing in personality disorders, and Dr. Joel Paris, senior psychiatrist at the JGH and editor-in-chief of The Canadian Journal of Psychiatry, will discuss ‘Predicting and preventing suicide: Do we know how to do either?’
Dr. Eric Jarvis, First Episode Psychosis Director, will discuss ‘Suicide in youth with First-Episode Psychosis: A research update.’
Dr. Laurence Kirmayer, Director, Culture and Mental Health Research Unit, Jewish General Hospital and James McGill Professor and Director, Division of Social and Transcultural Psychiatry, McGill University will discuss ‘Contexts of suicide among Aboriginal Peoples in Canada: Social suffering and resilience.’
Dr. J. Christopher Perry; Head of Psychotherapy Research, will discuss ‘Recovery from suicidal symptoms: What works for patients and their therapists.’
Dr. Gustavo Turecki, Vice-Chair, Research and Academic Affairs, Department of Psychiatry, McGill University and Director, Quebec Network of Suicide Research, Director, McGill Group for Suicidal Studies and Head, Depressive Disorders Program, Douglas Mental Health Institute, will moderate and chair an open discussion.
Information & Registration ►
Source: JGHFor generations, suicide and its symptoms were the health crisis no one wanted to talk about. Some of the top psychiatry researchers in Canada will gather this Friday for the Jewish General Hospital’s (JGH) Sixth Annual Psychiatry Research Day to shed light on this important problem, and will present recent research on the prediction and prevention of suicide, and the treatment of its symptoms.
Entitled ‘Suicide in Context: Perspectives on Risks, Assessment and Treatment’, the event is designed to update local health-care and social service professionals on the latest developments in suicide prevention research at the JGH.
“The work of clinician-scientists from the JGH Psychiatry Department is important in helping us to identify who is at risk for suicide, how to identify these people, and what we can do to help them,” said Dr. Phyllis Zelkowitz, the event organizer and director of the Psychiatry Research Division at the JGH.
Dr. Michael Bond, Chief of the JGH Department of Psychiatry will present opening remarks.
Dr. Robert Biskin, a McGill Department of Psychiatry resident specializing in personality disorders, and Dr. Joel Paris, senior psychiatrist at the JGH and editor-in-chief of The Canadian Journal of Psychiatry, will discuss ‘Predicting and preventing suicide: Do we know how to do either?’
Dr. Eric Jarvis, First Episode Psychosis Director, will discuss ‘Suicide in youth with First-Episode Psychosis: A research update.’
Dr. Laurence Kirmayer, Director, Culture and Mental Health Research Unit, Jewish General Hospital and James McGill Professor and Director, Division of Social and Transcultural Psychiatry, McGill University will discuss ‘Contexts of suicide among Aboriginal Peoples in Canada: Social suffering and resilience.’
Dr. J. Christopher Perry; Head of Psychotherapy Research, will discuss ‘Recovery from suicidal symptoms: What works for patients and their therapists.’
Dr. Gustavo Turecki, Vice-Chair, Research and Academic Affairs, Department of Psychiatry, McGill University and Director, Quebec Network of Suicide Research, Director, McGill Group for Suicidal Studies and Head, Depressive Disorders Program, Douglas Mental Health Institute, will moderate and chair an open discussion.
Information & Registration ►
Source: JGH